AlzeCure Pharma: AlzeCure Presents New Data at Alzheimer's Conference AD/PD on the Potential Disease-Modifying Effect of NeuroRestore ACD856

STOCKHOLM, SWEDEN / ACCESSWIRE / March 30, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Related Keywords

Sweden ,Stockholm ,Swedish ,Sanja Juric ,Cristina Parrado Fern ,Alzecure Pharma ,Nather Madjid ,Pontus Forsell ,Alzecure Pharmaview ,Gunnar Nordvall ,Johan Sandin ,Maria Backlund , ,Nasdaq First North Premier Growth Market ,Nerve Growth Factor ,Brain Derived Neurotrophic Factor ,Alzecure ,Dharma ,Presents ,Data ,Lzheimer ,Conference ,Potential ,Disease ,Modifying ,Effect ,Neurorestore ,Cd856 ,